Henry O. Gosebruch, Chief Strategy Officer at AbbVie Inc. (ABBV), sold 18,200 shares at $90.49 ($1.6M) on 2017-10-30, disclosed to the SEC on 2017-10-31.
Open-market sale of $1.6M ABBV by Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.38 | 2,150 | $192K | 11.7% |
| 2 | $90.49 | 11,568 | $1.0M | 63.5% |
| 3 | $91.22 | 4,482 | $409K | 24.8% |
| Total | $90.54 avg | 18,200 | $1.6M | 100% |
| Filing → |
| ABBV | SELL | 2022-05-20 | $13.0M | — | Filing → |
| ABBV | SELL | 2022-03-02 | $6.8M | — | Filing → |
| ABBV | SELL | 2022-03-01 | $2.2M | — | Filing → |